Amgen Profits Rise, Next MariTide Studies Start by Mid-Year
(Reuters) - Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key ...
Amgen price target raised to $329 from $310 at Piper Sandler
Piper Sandler raised the firm’s price target on Amgen (AMGN) to $329 from $310 and keeps an Overweight rating on the shares. The firm notes the ...
Reuters7d
Amgen profits rise, next MariTide studies start by mid-year
MariTide Phase 3 studies to begin in first half of year FDA places hold on AMG 513 obesity drug trial Amgen's Q4 earnings beat estimates, revenue up 11% Feb 4 (Reuters) - Amgen (AMGN.O), opens new ...
Yahoo Finance6d
Amgen profits rise, next MariTide studies start by mid-year
(Reuters) - Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug candidate MariTide will start before mid-year but regulators ...
Yahoo4d
Amgen Stock Has Surged. Here’s Where It’s Headed Next.
Here’s Where It’s Headed Next. All of a sudden, Amgen stock is up 15% since late December to around $299. Its rise helped push up the healthcare sector up just over 7% since hitting a bottom ...
Yahoo Finance14d
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth
Amgen (AMGN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives ...
Seeking Alpha4d
Amgen: Multiple Strengths, But The Valuation Is A Concern
Amgen is a biotechnology leader with competitive ... I expect the ratio to remain relatively stable over the next few years. The firm's free cash flow ("FCF") has risen because of more volume ...
Nasdaq6d
Amgen Surpasses Q4 Earnings Forecasts
Biotechnology specialist Amgen (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS ...